Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10.12x is 58% above its 5-year average of -24.12x, near the high end of its 5-year range (-71.00x–-6.13x).
51.40% above its 12-month average of -20.82x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -7.25x.
INTEREST COVERAGE RATIO
-10.12x
INTEREST COVERAGE RATIO AVG TTM
-20.82x
INTEREST COVERAGE RATIO AVG 3Y
-20.82x
INTEREST COVERAGE RATIO AVG 5Y
-24.12x
INTEREST COVERAGE RATIO AVG 10Y
-6.93x
INTEREST COVERAGE RATIO AVG 15Y
-7.35x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+51.40%
CURRENT VS 3Y AVG
+51.40%
CURRENT VS 5Y AVG
+58.05%
CURRENT VS 10Y AVG
-45.97%
CURRENT VS 15Y AVG
-37.72%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-139.24%
vs the sector median at left
ClearPoint Neuro, Inc.
Market Cap
$337.38M
Interest Coverage Ratio
-10.12x
TTM Avg
-20.82x
3Y Avg
-20.82x
5Y Avg
-24.12x
Market Cap
$340.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$342.72M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$326.11M
Interest Coverage Ratio
-85.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$325.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.30M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$357.37M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$357.44M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. (CLPT) | $337.38M | -10.12x | -20.82x | -20.82x | -24.12x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $340.28M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $342.72M | -0.37x | 0.39x | 0.39x | 0.39x |
| Cabaletta Bio, Inc. (CABA)vs › | $326.11M | -85.95x | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $325.07M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $322.44M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $353.30M | 3.07x | 2.31x | 3.74x | 3.74x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.37M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $357.44M | -3.05x | 0.61x | 0.61x | 0.61x |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $316.53M | -47.93x | N/A | N/A | N/A |
Interest Coverage
-10.1x
Debt/Equity
5.93
Current Ratio
4.73
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -7.25x |
| 2026-03-31 | -6.13x |
| 2025-12-31 | -10.02x |
| 2025-09-30 | -9.72x |
| 2025-06-30 | -71.00x |
| 2022-06-30 | -46.20x |
| 2022-03-31 | -36.45x |
| 2021-12-31 | -24.28x |
| 2021-09-30 | -15.98x |
| 2021-06-30 | -14.20x |
| 2021-03-31 | -6.57x |
| 2020-12-31 | -11.10x |
| 2020-09-30 | -6.32x |
| 2020-06-30 | -7.48x |
| 2020-03-31 | -1.44x |
| 2019-12-31 | -6.19x |
| 2019-09-30 | -4.27x |
| 2019-06-30 | -4.99x |
| 2019-03-31 | -3.83x |
| 2018-12-31 | -4.11x |
| 2018-09-30 | -4.89x |
| 2018-06-30 | -6.59x |
| 2018-03-31 | -5.77x |
| 2017-12-31 | -7.78x |
| 2017-09-30 | -6.28x |
| 2017-06-30 | -8.57x |
| 2017-03-31 | -6.34x |
| 2016-12-31 | -8.29x |
| 2016-09-30 | -7.09x |
| 2016-06-30 | -8.11x |
| 2016-03-31 | -5.53x |
| 2015-12-31 | -4.35x |
| 2015-09-30 | -6.08x |
| 2015-06-30 | -8.61x |
| 2015-03-31 | -9.80x |
| 2014-12-31 | -9.13x |
| 2014-09-30 | -9.07x |
| 2014-06-30 | -7.81x |
| 2014-03-31 | 14.73x |
| 2013-12-31 | -15.57x |
| 2013-09-30 | -14.58x |
| 2013-06-30 | -17.86x |
| 2013-03-31 | -13.87x |
| 2012-12-31 | -5.78x |
| 2012-09-30 | -11.85x |
| 2012-06-30 | -4.99x |
| 2012-03-31 | -0.50x |
| 2011-12-31 | -2.01x |
| 2011-09-30 | -2.03x |
| 2011-06-30 | -2.46x |
